000			02032 a2200553 4500
005			20250514024752.0
264		0	_c20020403
008			200204s 0 0 eng d
022			_a0021-9738
024	7		_a10.1172/JCI12736 _2doi
040			_aNLM _beng _cNLM
100	1		_aZollner, Thomas M
245	0	0	_aProteasome inhibition reduces superantigen-mediated T cell activation and the severity of psoriasis in a SCID-hu model. _h[electronic resource]
260			_bThe Journal of clinical investigation _cMar 2002
300			_a671-9 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAcetylcysteine _xanalogs & derivatives
650	0	4	_aAnimals
650	0	4	_aAntigens, CD _xmetabolism
650	0	4	_aAntigens, Differentiation, T-Lymphocyte _xmetabolism
650	0	4	_aBacterial Toxins
650	0	4	_aCysteine Endopeptidases
650	0	4	_aCysteine Proteinase Inhibitors _xpharmacology
650	0	4	_aDNA _xdrug effects
650	0	4	_aDisease Models, Animal
650	0	4	_aEnterotoxins _ximmunology
650	0	4	_aHLA-DR Antigens _xmetabolism
650	0	4	_aHumans
650	0	4	_aLectins, C-Type
650	0	4	_aLymphocyte Activation _xdrug effects
650	0	4	_aMice
650	0	4	_aMice, SCID
650	0	4	_aMultienzyme Complexes _xantagonists & inhibitors
650	0	4	_aNF-kappa B _xmetabolism
650	0	4	_aProteasome Endopeptidase Complex
650	0	4	_aPsoriasis _xdrug therapy
650	0	4	_aReceptors, Interleukin-2 _xmetabolism
650	0	4	_aSkin Transplantation _ximmunology
650	0	4	_aSuperantigens _xmetabolism
650	0	4	_aT-Lymphocytes _xdrug effects
650	0	4	_aTransplantation, Heterologous
700	1		_aPodda, Maurizio
700	1		_aPien, Christine
700	1		_aElliott, Peter J
700	1		_aKaufmann, Roland
700	1		_aBoehncke, Wolf-Henning
773	0		_tThe Journal of clinical investigation _gvol. 109 _gno. 5 _gp. 671-9
856	4	0	_uhttps://doi.org/10.1172/JCI12736 _zAvailable from publisher's website
999			_c11784631 _d11784631